Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNCOVERED: Vir biotechnology | History Defined

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Benzinga · Nov 4, 2022

5 Value Stocks To Watch In The Healthcare Sector

What Defines a Value Stock?

Benzinga · May 9, 2022

Where Vir Biotechnology Stands With Analysts

Within the last quarter, Vir Biotechnology (NASDAQ:VIR) has observed the following analyst ratings:

Benzinga · May 6, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Outlook For Vir Biotechnology

Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Vir Biotechnology will report an earnings per share (EPS) of $3.78.

Benzinga · May 4, 2022

5 Value Stocks In The Healthcare Sector

What are Value Stocks?

Benzinga · Apr 25, 2022

Why Did FDA Pull Authorization For GSK-Vir's COVID-19 Therapy? Read Here

The U.S. health regulator said GlaxoSmithKline Plc (NYSE:GSK) and Vir Biotechnology Inc's (NASDAQ:VIR) antibody therapy was no longer authorized as a COVID-19 treatment. The decision was made as the CDC now estimates that the proportion of Covid-19 cases caused by BA.2 is above 50% nationwide. "Sotrovimab is no longer authorized to treat COVID-19 in any…

Benzinga · Apr 6, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · Mar 30, 2022

Read news from The Economist, FT, and more,
with one subscription

35 Stocks Moving In Wednesday's Mid-Day Session

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales guidance above analyst estimates.

Benzinga · Mar 30, 2022

24 Stocks Moving in Wednesday's Pre-Market Session

Gainers

Benzinga · Mar 30, 2022

Recap: Vir Biotechnology Q4 Earnings

Vir Biotechnology (NASDAQ:VIR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 24, 2022

Coverage From

Benzinga

Organisations

Securities and Exchange Commission

Emergent BioSolutions

Revelation Biosciences

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

430,331 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.